Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900159 · ClinicalTrials.gov registry record · NA
Effects of Daytime Eszopiclone Administration in Shift Workers
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00900159 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 24 participants.
The verdict
NCT00900159, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of eszopiclone on daytime sleep and overnight wakefulness in shift workers.
Interventions
- DRUG matching placebo
- DRUG eszopiclone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00900159
The ClinicalTrials.gov registry entry for NCT00900159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which matching placebo is the first listed.
NCT00900159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00900159 about?
NCT00900159 is a clinical study titled "Effects of Daytime Eszopiclone Administration in Shift Workers". The purpose of this study is to test the effects of eszopiclone on daytime sleep and overnight wakefulness in shift workers.
What is the current status of trial NCT00900159?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2009-05. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00900159?
The interventions under investigation include: matching placebo (DRUG), eszopiclone (DRUG).
Who is sponsoring clinical trial NCT00900159?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.